These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192 [TBL] [Abstract][Full Text] [Related]
3. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285 [TBL] [Abstract][Full Text] [Related]
4. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. Huang T; Li F; Yan Z; Ma Y; Xiong F; Cai X; Zhang Q; Liu F; Dong J Medicine (Baltimore); 2018 Nov; 97(48):e13457. PubMed ID: 30508968 [TBL] [Abstract][Full Text] [Related]
6. Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339 [TBL] [Abstract][Full Text] [Related]
7. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET. Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127 [TBL] [Abstract][Full Text] [Related]
8. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Treglia G; Salsano M; Stefanelli A; Mattoli MV; Giordano A; Bonomo L Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239 [TBL] [Abstract][Full Text] [Related]
11. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717 [TBL] [Abstract][Full Text] [Related]
12. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma. Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716 [TBL] [Abstract][Full Text] [Related]
13. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719 [TBL] [Abstract][Full Text] [Related]
14. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up. Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma. Ruggiero A; Lanni V; Librizzi A; Maurizi P; Attinà G; Mastrangelo S; Giordano A; Riccardi R J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679 [TBL] [Abstract][Full Text] [Related]
17. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis. Zhang C; Liang Z; Liu W; Zeng X; Mo Y BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425 [TBL] [Abstract][Full Text] [Related]
19. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma? Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]